TEL AVIV, Israel--(BUSINESS WIRE)--Sight Diagnostics Ⓡ, the company behind the first FDA-cleared direct-from-fingerstick Complete Blood Count (CBC) analyzer, announced today it has raised $71 million ...

Earlier this year, a study conducted by the University of Edinburgh found that people who received the COVID-19 vaccine developed by AstraZeneca and the University of Oxford were at a very slightly ...